Harel Insurance Investments & Financial Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
Harel Insurance Investments & Financial Services's NVO Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services increased its Novo Nordisk (NVO) stake by 30% in Q2 2026, buying an estimated $98.3K and bringing the position to 9,962 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #250.
Harel Insurance Investments & Financial Services first reported a position in NVO in Q2 2016 and has held it in 21 quarters since. The position peaked at $57.7M in Q4 2023. 1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Harel Insurance Investments & Financial Services held 9,962 shares of Novo Nordisk worth $478K as of Q2 2026.
- Harel Insurance Investments & Financial Services bought 2,287 Novo Nordisk shares in Q2 2026, an estimated $98.3K.
- Novo Nordisk made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #250 holding.
- Harel Insurance Investments & Financial Services first reported a position in Novo Nordisk in Q2 2016 and has held it in 21 quarters since.
- Harel Insurance Investments & Financial Services's Novo Nordisk position peaked at $57.7M in Q4 2023.
- 1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.